Affordable Access

What they say about nucleotide drugs.

Type
Published Article
Journal
Positively aware : the monthly journal of the Test Positive Aware Network
Publication Date
Volume
10
Issue
1
Pages
44–44
Identifiers
PMID: 11366523
Source
Medline
License
Unknown

Abstract

A table provides information on Preveon (adefovir dipivoxil, PMEA), a nucleotide analog. An experimental drug available through expanded access, it is taken once daily as a component of combination therapy. Preveon also appears to have activity against various herpes viruses and hepatitis B. The drug is associated with serious kidney damage that is generally reversible after dose discontinuation. Gilead Sciences, the drug's manufacturer, a doctor, and a PWA activist offer comments. Contact information is provided.

Statistics

Seen <100 times